Candriam Equities L Biotechnology Class C USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 15.72 | -5.72 | 29.75 | 15.56 | -1.76 | 10.92 | 1.12 | 6.56 |
+/- Category | 5.42 | 2.25 | 9.55 | -10.41 | 7.27 | 18.76 | 2.40 | 7.11 |
+/- Category Index | 0.53 | -3.87 | 13.04 | -17.37 | -2.06 | 8.46 | -6.21 | -11.31 |
% Rank in Category | 24 | 35 | 10 | 72 | 35 | 2 | 31 | 21 |
Trailing Returns (GBP) | 12/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.45 | -1.42 | 0.74 |
1 Week | 5.68 | -0.36 | 4.70 |
1 Month | 6.93 | 3.04 | 5.03 |
3 Months | 10.24 | 9.19 | -1.32 |
6 Months | 7.39 | 5.59 | -8.76 |
YTD | 10.69 | 8.58 | -7.23 |
1 Year | 21.48 | 10.97 | -14.87 |
3 Years Annualised | 7.16 | 11.18 | -1.38 |
5 Years Annualised | 9.88 | 2.55 | -3.00 |
10 Years Annualised | 11.34 | 1.52 | -0.71 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.73 | 2.73 | - | - |
2023 | -5.35 | -0.10 | -1.34 | 8.39 |
2022 | -4.00 | -0.05 | 13.44 | 1.91 |
2021 | -5.97 | 6.60 | 0.42 | -2.39 |
2020 | -5.34 | 25.01 | -5.87 | 3.75 |
2019 | 13.85 | 1.72 | -5.85 | 19.01 |
|
Advertisement |